Targeted immunotherapy for HER2-low breast cancer with 17p loss

Li, YJ; Sun, YF; Kulke, M; Hechler, T; Van der Jeught, K; Dong, TH; He, B; Miller, KD; Radovich, M; Schneider, BP; Pahl, A; Zhang, XN; Lu, XB

Zhang, XN; Lu, XB (corresponding author), Indiana Univ Sch Med, Dept Med & Mol Genet, Indianapolis, IN 46202 USA.; Zhang, XN; Lu, XB (corresponding author), Indiana Univ Sch Med, Indiana Univ, Melvin & Bren Simon Canc Ctr, Indianapolis, IN 46202 USA.; Lu, XB (corresponding author), Indiana Univ Sch Med, Indiana Univ, Ctr Computat Biol & Bioinformat, Indianapolis, IN 46202 USA.

SCIENCE TRANSLATIONAL MEDICINE, 2021; 13 (580):

Abstract

The clinical challenge for treating HER2 (human epidermal growth factor receptor 2)-low breast cancer is the paucity of actionable drug targets. HER2-......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索